Stem cell particles for lung scarring
Part of Lungs & breathing clinical trials.
This study tests an experimental treatment using tiny particles from human stem cells, given through a nebulizer (breathing mist). It aims to see if this treatment is safe and can help improve lung function in people with interstitial lung disease (lung scarring).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a diagnosis of interstitial lung disease (ILD), which is a group of conditions that cause scarring of the lungs.
- Your most recent lung scan (CT) must show changes typical of ILD, and this scan should be from the last 3 months.
- Your lung function test results must be within a certain range that the study team will check.
- You must be willing to follow the study procedures, attend scheduled visits, and sign a consent form to participate.
- You cannot be on oxygen for more than 15 hours a day, have had cancer in the last 5 years, or have active infections like hepatitis B, C, or HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a patient's own lung stem cells can be used to repair damaged lungs in people with interstitial lung disease. It is an early-stage trial to see if the treatment is safe and may help improve breathing.
This trial tests a new treatment using stem cells from umbilical cords to help people with scleroderma-related lung disease. It aims to see if the treatment can slow down or improve lung scarring and breathing problems.
This study tests whether a single injection of stem cells from umbilical cord blood can improve lung function in people with interstitial lung disease. It might help reduce inflammation or repair damaged lung tissue.
This trial tests whether a new treatment made from menstrual blood stem cells, given by injection, can help people with IPF, a condition that causes lung scarring and makes breathing harder. The study aims to see if the treatment can slow down the disease and improve lung function.
This study tests a new treatment that is breathed in as a mist (nebulized) and uses tiny particles from cells (called extracellular vesicles) to help calm the immune system. It is for people with IgG4-related disease or systemic sclerosis that have lung problems, and may help reduce inflammation and improve breathing.
This trial tests a treatment made from human umbilical cord stem cells for people with moderate ARDS. The goal is to see if it is safe and well-tolerated, and if it might help the lungs recover faster.
Hear when a new Interstitial Lung Disease (ILD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.